AAMC Home   Tomorrow's Doctors Tomorrow's Cures
  Home  Government Affairs   Newsroom   Meetings   Publications Shopping Cart   Site Map    

 

Home

Washington Highlights

Testimony & Correspondence

Top Issues:

 

Education

 

GME & IME Payments

HIPAA

Labor-HHS Appropriations

Research

Teaching Hospitals

Teaching Physicians

Veterans Affairs

Workforce

Government Affairs & Advocacy Site Map

Contact

 

Government Affairs Home > Labor-HHS Appropriations > Bioterrorism

AAMC Letter to Select Committee on Homeland Security on Proposed Department of Homeland Security

July 18, 2002

The Honorable Richard Armey
Chairman
Select Homeland Security Committee
United States House of Representatives
Washington, D.C. 20515

Dear Mr. Chairman:

The Association of American Medical Colleges (AAMC) supports the establishment of a Department of Homeland Security (DHS) to provide oversight, coordination and leadership for activities to respond to the threat of bioterrorism. The terrorist attacks of September 11 and the subsequent incidents involving anthrax-contaminated mail demonstrate the severity and complexity of the medical consequences for the civilian population of terrorist acts, particularly those involving biological, chemical, or nuclear agents. These events also reinforce the need for a comprehensive, coordinated program of medical research and public health activities to prepare for and respond to such attacks.

The AAMC believes it is critical that the proposed DHS build upon existing research and public health programs that hold promise in the defense against bioterrorism. The AAMC commends and endorses the House Energy and Commerce Committee's bipartisan recommendations for the Department of Health and Human Services (HHS) within H.R. 5005, which establishes the Department of Homeland Security. The AAMC believes the approach adopted by the Energy and Commerce Committee, which retains authorities for human health related research and public health within HHS, is appropriate and will help to ensure that biodefense research and public health efforts in the United States are successful.

There is a need for a greater scientific understanding of the threats posed by potential bioterrorist agents. However, biodefense research is part of the broader medical research continuum. We believe that the Administration's proposal to transfer primary responsibility for biodefense research to DHS would create unpredictability for research programs, would increase the possibility of duplicative research, and would not be the optimum way to obtain the integrated work of the best scientific minds.

It is important to distinguish between oversight and coordination activities, which should be the responsibility of DHS, and the direction, support, and conduct of research, which should continue to reside with the National Institutes of Health (NIH) and HHS. DHS must have the ability to direct the research effort into areas that are known to be a potential threat. At the same time, NIH needs to be responsive to such direction when scientifically credible. Therefore, we believe it is important for DHS and HHS/NIH to collaborate on the development of research riorities, but that HHS, a scientific health agency, continue to prioritize, conduct and fund federal research related to civilian, human health-related biological, biomedical, and infectious diseases, as recommended in the House Energy and Commerce Bill.

With regard to public health programs, we recognize the necessity of coordinating federal, state, and local health preparedness and response programs to respond to public health emergencies, including bioterrorist attacks. However, we share the concerns expressed by the General Accounting Office and others about the proposed transfer of control from HHS to DHS of those public health programs that have homeland security as well as basic public health functions. These dual-purpose programs have important synergies that should be maintained. We concur with the recommendations of the Energy and Commerce Committee that HHS should retain control, including priority setting, of these programs that are critical to basic public health responsibilities.

Therefore, AAMC strongly endorses the approach of the Energy and Commerce Committee Bill that HHS retains primary control and funding authority for research and public health programs, in consultation and coordination with DHS. The Energy and Commerce Bill will ensure that NIH, CDC, and HRSA will continue to direct research, infectious disease control, emergency preparedness and essential dual-purpose public health activities.

In addition, the AAMC supports the recommendation of the House Agriculture Committee to split the Animal and Plant Health Inspection Service (APHIS) and transfer only its border inspection service and its Plum Island animal disease lab to DHS. We believe this appropriately separates the responsibility for protection of the nation's food supply from the ongoing oversight and implementation of the Animal Welfare Act.

AAMC is committed to working with the Congress and the Administration to improve the nation's response to the threat posed by biological agents and would be pleased to provide any assistance in considering the vital issues arising from the threat of bioterrorism.

Sincerely,

Jordan J. Cohen, M.D.

cc: The Honorable Billy Tauzin
The Honorable John Dingell
The Honorable Michael Bilirakis
The Honorable Sherrod Brown
The Honorable Jim Greenwood
The Honorable Peter Deutsch

Contact Us    © 1995-2008 AAMC    Terms and Conditions    Privacy Statement